Acetylcysteine Injection, Solution
Product Images NDC 63323-963

6 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 63323-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prx Ctnpdp (Prxaceinjctnpdp)

Prx Ctnpdp (Prxaceinjctnpdp)
Label of Acetylcysteine Injection solution, 6 grams per 30 mL (200 mg/mL), in single dose vials. The label indicates the product must be further diluted prior to intravenous use and unused portions discarded. Package includes 4 x 30 mL vials. Labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Prxvialpdp (Prxaceinjvialpdp)

Prxvialpdp (Prxaceinjvialpdp)
Label for Acetylcysteine Injection, 6 grams per 30 mL (200 mg/mL) intravenous solution in a 30 mL single-dose vial. The label includes dilution instructions prior to intravenous use and indicates it is prescription only. The product is from Fresenius Kabi USA, LLC with NDC 63323-963.*
FDA Label Image
FDA Label Image

Figure 1 (Acetylcysteine 01)

Figure 1 (Acetylcysteine 01)
A line graph depicting acetaminophen plasma concentration (in μM and μg/ml) over 24 hours after ingestion. The chart is divided into zones indicating 'No hepatic toxicity,' 'Possible hepatic toxicity,' and 'Probable hepatic toxicity,' showing the relationship between acetaminophen levels and potential liver toxicity risk over time.*
FDA Label Image

Figure 2 (Acetylcysteine 02)

Figure 2 (Acetylcysteine 02)
A flowchart illustrating the decision process for administration of acetylcysteine based on timing and acetaminophen serum levels. It starts with estimating acetaminophen ingestion time, then directs actions based on serum level measurement and ingestion reliability, guiding whether to administer or stop acetylcysteine therapy.*
FDA Label Image

Figure 3 (Acetylcysteine 03)

Figure 3 (Acetylcysteine 03)
Chemical structure of acetylcysteine, showing its molecular arrangement with labeled atoms including carbon, hydrogen, nitrogen, oxygen, and sulfur. The structure highlights key functional groups such as the acetyl group and thiol (-SH) group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.